𝐓𝐡𝐞 𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐑𝐨𝐛𝐨𝐭𝐬 𝐢𝐬 𝐚𝐛𝐨𝐮𝐭 𝐭𝐨 𝐞𝐱𝐩𝐥𝐨𝐝𝐞, give a look to this analisys:
From USD 16.0 billion in 2024 to USD 33.8 billion by 2029
That kind of growth doesn’t happen by accident.
→ The world is aging.
→ Chronic diseases are rising.
→ Hospitals are under pressure to do more with fewer people.
So, healthcare is turning to automation—fast.
With 8,606 da Vinci systems installed and 2.28 million procedures performed in 2023, their impact is undeniable.
They invested nearly USD 1 billion in R&D last year alone to keep pushing what’s possible.
Then there’s Stryker.
After acquiring Mako Surgical in 2013, they’ve become a force in orthopedic robotics.
Their Mako systems for hips and knees are redefining precision surgery.
In 2023, three-quarters of Stryker’s sales came from the US—but their global footprint keeps growing.
𝐓𝐡𝐢𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐬𝐧’𝐭 𝐣𝐮𝐬𝐭 𝐜𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞.
It’s transforming how healthcare operates.
Hospitals that invest in robotics now aren’t just upgrading technology.
They’re buying time, precision, and better patient outcomes.
The question isn’t whether medical robots will dominate.
It’s which companies will set the new standard.
eXinvest of Emirates is going to introduce a strong partnership with a worldwide leader in medical robotic surgery.
Proud to meet you soon at our event!
www.eXinvest.ae
www.finchemo.com
This email address is being protected from spambots. You need JavaScript enabled to view it.
